Jiri Sramek
Pilsen, PL, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.
Journal: Leukemia
Published: August 15, 2025
Real-World Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia: Insights From the Czech Republic.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 14, 2025
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis.
Journal: British journal of haematology
Published: May 11, 2024
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.
Journal: Annals of hematology
Published: September 17, 2023
Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.
Journal: Leukemia research
Published: December 27, 2022
Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience.
Journal: Neoplasma
Published: July 20, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Journal: Haematologica
Published: February 11, 2022
Single-Nucleotide Polymorphisms in MICA and MICB Genes Could Play a Role in the Outcome in AML Patients after HSCT.
Journal: Journal of clinical medicine
Published: August 08, 2021
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
Journal: Bone marrow transplantation
Published: August 24, 2020
Last Updated: 09/26/2026